Search

everythinglearnresearchcommunity

for

Search:↓

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Dopamine receptors in the brain influence itch-related scratching behavior.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

Using too much minoxidil foam can cause a rare movement disorder with facial twitching, but symptoms go away when the correct dose is used.

Hormonal imbalance contributes to chronic prostatitis and affects male reproductive health.

Finasteride may cause changes in dopamine-related genes, possibly leading to post-finasteride syndrome.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Dutasteride may protect the brain in early Parkinson's disease.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Stopping aripiprazole can reverse its side effect of hair loss.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Finasteride reduces movement issues in Parkinson's disease rats.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Finasteride given to baby rats reduces dopamine release and increases alcohol consumption in adult males.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.